NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto's initial public offering conducted on or about February 2, 2024 (the "IPO†); and/or (ii) securities between February 2, 2024 and October 22, 2024. Alto describes itself as a "clinical-stage biopharmaceutical company in the U.S.†For more infor. ...